Search
for
Sort by
Research 211–240 of 1000+
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- POS0080 TOFACITINIB TREATMENT IN CHILDREN WITH RHEUMATIC DISEASES: SINGLE-CENTER EXPERIENCE
- BH14 Irish dermatologists’ experience with Janus kinase inhibitors in alopecia areata
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Alopecia areata in children: an overview of clinical features and recent treatment options
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Alopecia Areata and Alopecia Areata Incognita
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Alopecia Areata
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Alopecia areata following COVID-19 vaccine: a systematic review
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Alopecia Areata
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- A case of refractory alopecia areata successfully treated by combining delgocitinib ointment with excimer laser